USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS
The present invention relates to the use of compounds from the group of 3-aza-l-oxadibenzo[e,h]azulenes and of their pharmacologically acceptable salts and solvates for the manufacture of a pharmaceutical formulation for the treatment and prevention of diseases, damages and disorders of the central...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PESIC, DIJANA MERCEP, MLADEN DZAPO, IVA MESIC, MILAN |
| description | The present invention relates to the use of compounds from the group of 3-aza-l-oxadibenzo[e,h]azulenes and of their pharmacologically acceptable salts and solvates for the manufacture of a pharmaceutical formulation for the treatment and prevention of diseases, damages and disorders of the central nervous system (CNS) caused by disorders of the neurochemical equilibrium of biogenic amines or other neurotransmitters.
L'invention porte sur l'utilisation de composés du groupe des 3-aza-1-oxa-dibenzo[e,h]azulènes et de leurs sels et solvates pharmaceutiquement acceptables dans la fabrication d'une formulation pharmaceutique destinée au traitement de maladies, lésions et troubles du système nerveux central (SNC) causés par des altérations dans l'équilibre neurochimique des amines biogéniques et autres neurotransmetteurs. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005049036A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005049036A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005049036A13</originalsourceid><addsrcrecordid>eNqNi8FqwkAQQHPpodj-w0CvXUiatuBxupmQQHZXZmdTGykisuJBNGA_qx_pKoJXT-8d3nvM_oMncDWUCgdUhXJzVFX7RXZwsIiv21_AIXRkyUPtGKQhMGhDjVoCX85Zg2xQU5BWY3euTOhQWmdvizChGLICaCuYMfXJU3H-dVJOoyXuXfDgf7yQgar1hP7SJ3VcEfun7GGz2h3j85WT7KUm0Y2K42EZj-NqHffxb_nt3vL8I3-f5uUnFuV91QnbuUlF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS</title><source>esp@cenet</source><creator>PESIC, DIJANA ; MERCEP, MLADEN ; DZAPO, IVA ; MESIC, MILAN</creator><creatorcontrib>PESIC, DIJANA ; MERCEP, MLADEN ; DZAPO, IVA ; MESIC, MILAN</creatorcontrib><description>The present invention relates to the use of compounds from the group of 3-aza-l-oxadibenzo[e,h]azulenes and of their pharmacologically acceptable salts and solvates for the manufacture of a pharmaceutical formulation for the treatment and prevention of diseases, damages and disorders of the central nervous system (CNS) caused by disorders of the neurochemical equilibrium of biogenic amines or other neurotransmitters.
L'invention porte sur l'utilisation de composés du groupe des 3-aza-1-oxa-dibenzo[e,h]azulènes et de leurs sels et solvates pharmaceutiquement acceptables dans la fabrication d'une formulation pharmaceutique destinée au traitement de maladies, lésions et troubles du système nerveux central (SNC) causés par des altérations dans l'équilibre neurochimique des amines biogéniques et autres neurotransmetteurs.</description><edition>7</edition><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050602&DB=EPODOC&CC=WO&NR=2005049036A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050602&DB=EPODOC&CC=WO&NR=2005049036A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PESIC, DIJANA</creatorcontrib><creatorcontrib>MERCEP, MLADEN</creatorcontrib><creatorcontrib>DZAPO, IVA</creatorcontrib><creatorcontrib>MESIC, MILAN</creatorcontrib><title>USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS</title><description>The present invention relates to the use of compounds from the group of 3-aza-l-oxadibenzo[e,h]azulenes and of their pharmacologically acceptable salts and solvates for the manufacture of a pharmaceutical formulation for the treatment and prevention of diseases, damages and disorders of the central nervous system (CNS) caused by disorders of the neurochemical equilibrium of biogenic amines or other neurotransmitters.
L'invention porte sur l'utilisation de composés du groupe des 3-aza-1-oxa-dibenzo[e,h]azulènes et de leurs sels et solvates pharmaceutiquement acceptables dans la fabrication d'une formulation pharmaceutique destinée au traitement de maladies, lésions et troubles du système nerveux central (SNC) causés par des altérations dans l'équilibre neurochimique des amines biogéniques et autres neurotransmetteurs.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi8FqwkAQQHPpodj-w0CvXUiatuBxupmQQHZXZmdTGykisuJBNGA_qx_pKoJXT-8d3nvM_oMncDWUCgdUhXJzVFX7RXZwsIiv21_AIXRkyUPtGKQhMGhDjVoCX85Zg2xQU5BWY3euTOhQWmdvizChGLICaCuYMfXJU3H-dVJOoyXuXfDgf7yQgar1hP7SJ3VcEfun7GGz2h3j85WT7KUm0Y2K42EZj-NqHffxb_nt3vL8I3-f5uUnFuV91QnbuUlF</recordid><startdate>20050602</startdate><enddate>20050602</enddate><creator>PESIC, DIJANA</creator><creator>MERCEP, MLADEN</creator><creator>DZAPO, IVA</creator><creator>MESIC, MILAN</creator><scope>EVB</scope></search><sort><creationdate>20050602</creationdate><title>USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS</title><author>PESIC, DIJANA ; MERCEP, MLADEN ; DZAPO, IVA ; MESIC, MILAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005049036A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PESIC, DIJANA</creatorcontrib><creatorcontrib>MERCEP, MLADEN</creatorcontrib><creatorcontrib>DZAPO, IVA</creatorcontrib><creatorcontrib>MESIC, MILAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PESIC, DIJANA</au><au>MERCEP, MLADEN</au><au>DZAPO, IVA</au><au>MESIC, MILAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS</title><date>2005-06-02</date><risdate>2005</risdate><abstract>The present invention relates to the use of compounds from the group of 3-aza-l-oxadibenzo[e,h]azulenes and of their pharmacologically acceptable salts and solvates for the manufacture of a pharmaceutical formulation for the treatment and prevention of diseases, damages and disorders of the central nervous system (CNS) caused by disorders of the neurochemical equilibrium of biogenic amines or other neurotransmitters.
L'invention porte sur l'utilisation de composés du groupe des 3-aza-1-oxa-dibenzo[e,h]azulènes et de leurs sels et solvates pharmaceutiquement acceptables dans la fabrication d'une formulation pharmaceutique destinée au traitement de maladies, lésions et troubles du système nerveux central (SNC) causés par des altérations dans l'équilibre neurochimique des amines biogéniques et autres neurotransmetteurs.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2005049036A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | USE OF 3-AZA-1-OXA-DIBENZO [e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T16%3A51%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PESIC,%20DIJANA&rft.date=2005-06-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005049036A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |